197 related articles for article (PubMed ID: 20846114)
21. Skeletal muscle mitogen-activated protein kinases and ribosomal S6 kinases. Suppression in chronic diabetic rats and reversal by vanadium.
Hei YJ; Chen X; Pelech SL; Diamond J; McNeill JH
Diabetes; 1995 Oct; 44(10):1147-55. PubMed ID: 7556949
[TBL] [Abstract][Full Text] [Related]
22. Vanadium Compounds as PTP Inhibitors.
Irving E; Stoker AW
Molecules; 2017 Dec; 22(12):. PubMed ID: 29257048
[TBL] [Abstract][Full Text] [Related]
23. Titanium and vanadium complexes as anticancer agents.
Kostova I
Anticancer Agents Med Chem; 2009 Oct; 9(8):827-42. PubMed ID: 19538167
[TBL] [Abstract][Full Text] [Related]
24. Vanadium Compounds with Antidiabetic Potential.
Amaral LMPF; Moniz T; Silva AMN; Rangel M
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958659
[TBL] [Abstract][Full Text] [Related]
25. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research.
Domingo JL; Gómez M
Food Chem Toxicol; 2016 Sep; 95():137-41. PubMed ID: 27417449
[TBL] [Abstract][Full Text] [Related]
26. Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.
Treviño S; Díaz A; Sánchez-Lara E; Sanchez-Gaytan BL; Perez-Aguilar JM; González-Vergara E
Biol Trace Elem Res; 2019 Mar; 188(1):68-98. PubMed ID: 30350272
[TBL] [Abstract][Full Text] [Related]
27. Is the hypoglycemic action of vanadium compounds related to the suppression of feeding?
Huang M; Wu Y; Wang N; Wang Z; Zhao P; Yang X
Biol Trace Elem Res; 2014 Mar; 157(3):242-8. PubMed ID: 24446192
[TBL] [Abstract][Full Text] [Related]
28. Vanadium Compounds as Pro-Inflammatory Agents: Effects on Cyclooxygenases.
Korbecki J; Baranowska-Bosiacka I; Gutowska I; Chlubek D
Int J Mol Sci; 2015 Jun; 16(6):12648-68. PubMed ID: 26053397
[TBL] [Abstract][Full Text] [Related]
29. Anti-diabetic and toxic effects of vanadium compounds.
Srivastava AK
Mol Cell Biochem; 2000 Mar; 206(1-2):177-82. PubMed ID: 10839208
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?
Cam MC; Brownsey RW; McNeill JH
Can J Physiol Pharmacol; 2000 Oct; 78(10):829-47. PubMed ID: 11077984
[TBL] [Abstract][Full Text] [Related]
31. Health Benefits of Vanadium and Its Potential as an Anticancer Agent.
Crans DC; Yang L; Haase A; Yang X
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394028
[TBL] [Abstract][Full Text] [Related]
32. Effects of vanadium complexes supplementation on V, Fe, Cu, Zn, Mn, Ca and K concentration in STZ diabetic rat's spleen.
Krośniak M; Francik R; Kowalska J; Gryboś R; Blusz M; Kwiatek WM
Acta Pol Pharm; 2013; 70(1):71-7. PubMed ID: 23610961
[TBL] [Abstract][Full Text] [Related]
33. Vanadium as potential therapeutic agent for COVID-19: A focus on its antiviral, antiinflamatory, and antihyperglycemic effects.
Semiz S
J Trace Elem Med Biol; 2022 Jan; 69():126887. PubMed ID: 34798510
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional actions of vanadium compounds on insulin signaling pathways: evidence for preferential enhancement of metabolic versus mitogenic effects.
Fantus IG; Tsiani E
Mol Cell Biochem; 1998 May; 182(1-2):109-19. PubMed ID: 9609120
[TBL] [Abstract][Full Text] [Related]
35. Effects of oral vanadium on glycaemic and lipid profile in rats.
Hussain Shah SZ; Naveed AK; Rashid A
J Pak Med Assoc; 2016 Dec; 66(12):1592-1596. PubMed ID: 28179696
[TBL] [Abstract][Full Text] [Related]
36. Vanadium complexes with mixed O,S anionic ligands derived from maltol: synthesis, characterization, and biological studies.
Monga V; Thompson KH; Yuen VG; Sharma V; Patrick BO; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2678-88. PubMed ID: 15819553
[TBL] [Abstract][Full Text] [Related]
37. Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis.
Bevan AP; Drake PG; Yale JF; Shaver A; Posner BI
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):49-58. PubMed ID: 8927047
[TBL] [Abstract][Full Text] [Related]
38. Studies of vanadyl sulfate as a glucose-lowering agent in STZ-diabetic rats.
Thompson KH; Leichter J; McNeill JH
Biochem Biophys Res Commun; 1993 Dec; 197(3):1549-55. PubMed ID: 8280174
[TBL] [Abstract][Full Text] [Related]
39. Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.
Saatchi K; Thompson KH; Patrick BO; Pink M; Yuen VG; McNeill JH; Orvig C
Inorg Chem; 2005 Apr; 44(8):2689-97. PubMed ID: 15819554
[TBL] [Abstract][Full Text] [Related]
40. Vanadium chemistry and biochemistry of relevance for use of vanadium compounds as antidiabetic agents.
Crans DC; Mahroof-Tahir M; Keramidas AD
Mol Cell Biochem; 1995 Dec 6-20; 153(1-2):17-24. PubMed ID: 8927035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
